Professor Paul Hofman, Director of the RespirERA Institute, has joined the international expert panel of Iylon Precision Oncology, a platform dedicated to precision oncology. This collaboration contributes to disseminating the institute's expertise in molecular pathology, biomarkers, and liquid biopsy to patients and clinicians worldwide.
A platform dedicated to precision oncology
Iylon Precision Oncology is an international platform whose ambition is to facilitate access to precision oncology expertise, regardless of the patients' geographical location. Its model is based on connecting doctors and patients with a global network of specialists capable of interpreting complex molecular data and contributing to the definition of personalized therapeutic strategies.
The objective is to allow medical teams to benefit from specialized opinions based on the genomic analysis of tumors and on the latest advances in precision medicine.
Professor Paul Hofman within an international expert panel
Within this framework, Professor Paul Hofman has joined the advisory expert panel of Iylon Precision Oncology alongside specialists from leading institutions such as Harvard, the Dana-Farber Cancer Institute, the MD Anderson Cancer Center, or Brown University.
His recognized expertise in the fields of thoracic pathology, biomarkers, and liquid biopsy will contribute to the analysis of complex clinical situations requiring an in-depth interpretation of molecular data.
This activity notably includes the evaluation of tumor genomic profiles, the interpretation of predictive biomarkers of treatment response, and the analysis of results from tissue or liquid biopsies.
An international recognition for the RespirERA Institute
This appointment bears witness to the international recognition of the expertise developed within the RespirERA Institute in the field of precision oncology.
It aligns fully with several strategic axes of the institute, notably the development of biomarkers, the use of liquid biopsies, integrative pathology, and the integration of artificial intelligence into diagnostic tools.
Through this participation, the expertise developed in Nice can be shared within an international network bringing together specialists from four continents.
Accelerating the transfer of innovations to patients
The presence of Professor Paul Hofman within this platform also contributes to bringing research advances closer to clinical needs. The innovations developed in the fields of biomarkers, immunotherapy, and personalized medicine can thus feed the reflections carried out within international expert committees.
This dynamic promotes knowledge sharing, the development of new scientific collaborations, and the dissemination of best practices in precision oncology.
The integration of Professor Paul Hofman into the international expert panel of Iylon Precision Oncology illustrates the growing influence of the RespirERA Institute in the field of precision oncology and places the institute within an international network mobilized to develop an ever more personalized, innovative, and patient-accessible medicine.
FR 
EN 